We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$394B
AUM Growth
+$44.6B
Cap. Flow
+$6.63B
Cap. Flow %
1.68%
Top 10 Hldgs %
19.2%
Holding
3,619
New
44
Increased
2,356
Reduced
681
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Financials 12.41%
3 Healthcare 11.8%
4 Consumer Discretionary 10.03%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSBX
3426
DELISTED
Turnstone Biologics
TSBX
$38.6K ﹤0.01%
15,169
AQST icon
3427
Aquestive Therapeutics
AQST
$553M
$38.5K ﹤0.01%
19,078
CTMX icon
3428
CytomX Therapeutics
CTMX
$752M
$38.5K ﹤0.01%
24,817
AXTI icon
3429
AXT Inc
AXTI
$4.83B
$38.1K ﹤0.01%
15,887
BDSX icon
3430
Biodesix
BDSX
$256M
$37.9K ﹤0.01%
1,031
BIVI icon
3431
BioVie
BIVI
$9.58M
$37.7K ﹤0.01%
299
+183
+158% +$55K
DMAC icon
3432
DiaMedica Therapeutics
DMAC
$370M
$37.6K ﹤0.01%
13,251
ATYR
3433
aTyr Pharma
ATYR
$52.4M
$37.6K ﹤0.01%
26,689
IMUX icon
3434
Immunic
IMUX
$211M
$37.5K ﹤0.01%
2,500
FARM
3435
DELISTED
Farmer Brothers
FARM
$36K ﹤0.01%
11,781
NAGE
3436
Niagen Bioscience
NAGE
$244M
$35.3K ﹤0.01%
24,667
DFLI icon
3437
Dragonfly Energy
DFLI
$18.5M
$35.1K ﹤0.01%
719
BEAT icon
3438
Heartbeam
BEAT
$32.6M
$34.2K ﹤0.01%
14,543
MPU icon
3439
Mega Matrix
MPU
$14.9M
$34.1K ﹤0.01%
24,173
SND icon
3440
Smart Sand
SND
$200M
$33.7K ﹤0.01%
17,439
JOB icon
3441
GEE Group
JOB
$21.2M
$33.3K ﹤0.01%
66,522
SUP
3442
DELISTED
Superior Industries International
SUP
$33.1K ﹤0.01%
10,350
MCHX icon
3443
Marchex
MCHX
$77.1M
$33.1K ﹤0.01%
24,313
LODE icon
3444
Comstock
LODE
$270M
$32.8K ﹤0.01%
5,993
APYX icon
3445
Apyx Medical
APYX
$127M
$32.7K ﹤0.01%
12,488
VANI icon
3446
Vivani Medical
VANI
$120M
$30.6K ﹤0.01%
30,017
USIO icon
3447
Usio Inc
USIO
$61.5M
$30.6K ﹤0.01%
17,787
LPTH icon
3448
Lightpath Technologies
LPTH
$822M
$30.5K ﹤0.01%
24,173
MAPS
3449
DELISTED
WM TECHNOLOGY INC A
MAPS
$29.5K ﹤0.01%
40,927
HOOK
3450
DELISTED
HOOKIPA Pharma
HOOK
$29.4K ﹤0.01%
3,629

Similar funds

Charles Schwab's Q4 2023 Portfolio in Review

As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
  • Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
  • Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
  • Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
  • Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
  • Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
  • Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.